Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CCRL2 Stable Cell Line

    [CAT#: S01YF-0923-PY54]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    CCRL2
    Target Family
    Chemokine Family
    Target Protein Species
    Human
    Host Cell Type
    MDS92;MDS-L;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Rheumatoid Arthritis ;Arthritis
    Gene ID
    Human: 9034
    UniProt ID
    Human: O00421

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CCRL2 Stable Cell Line (S01YF-0923-PY54). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Ronald (Verified Customer)

    How does CCRL2 contribute to antitumor T-cell immunity? Sep 26 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CCRL2 has been found to activate immunostimulatory macrophages, thereby amplifying antitumor T-cell responses and promoting tumor rejection. This suggests that CCRL2 could be a potential biomarker and therapeutic target for cancer immunotherapy. Sep 26 2020

    chat Michelle (Verified Customer)

    What role does CCRL2 play in myelodysplastic syndrome and secondary acute myeloid leukemia? Apr 25 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CCRL2 is up-regulated in primitive cells from patients with myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia (sAML). It acts as a growth mediator for MDS/sAML cells, partially through the JAK2/STAT signaling pathway. Apr 25 2020
    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare